1 March 2021 in Hospital Practice
There is increasing evidence of the ability of the novel coronavirus to invade the central nervous system (CNS). But how does a respiratory virus invade the highly protected CNS? Here, we reviewed available literature and case reports to determine CNS involvement in COVID-19, and to identify potential regions of the brain that may be affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its possible route of entry into the brain to identify its pathogenicity. Based on the symptoms, the parietal lobe and the cerebellum are the likely targets of SARS-CoV-2, however further work is needed to elucidate this. The presence of ACE2, used by SARS-CoV-2 for cell entry, in the brain as well as detection of the virus in the cerebrospinal fluid, further assert that SARS-COV-2 targets the brain, and therefore, medical practitioners should take that into account when dealing with patients suffering from COVID-19.
20 October 2020 in Hospital Practice
Coronavirus disease 2019 (COVID-19) instigated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected more`` than 20 million people, with more than more than 700000 deaths globally; and has been declared a pandemic. SARS-CoV-2 is recognized as the seventh coronavirus affecting Homo sapiens. The symptoms of COVID-19 consist of an elevated temperature, cough, diarrhea, and vomiting amongst others, whereas the transmission of SARS-CoV-2 is believed to arise via release of respiratory secretions; through sneezing and coughing. COVID-19 is identified via X-ray or computed tomography scans and further corroborated with molecular diagnostics techniques, including polymerase chain reaction. At present there are no successful therapeutics against SARS-CoV-2; existing antiviral therapies have been utilized to hinder manifestation of respiratory difficulties by diminishing viral load. Herein, we depict an extensive update on the clinical aspects of COVID-19, including strategies for the regulation of the transmission, diagnosis, treatment, and pathogenesis of SARS-CoV-2 infections.
5 December 2025 in Nature Communications
Physiologically relevant increases in transcription factor dosage and their role in development and disease remain largely unexplored. Genomic deletions upstream of the Paired-like homeodomain transcription factor gene ( PITX2 ), identified in patients with sinus node dysfunction and atrial fibrillation and modeled in mice ( delB ), rewire the local epigenetic landscape, increasing PITX2 expression. Here, we demonstrate that pacemaker cardiomyocytes in the embryonic delB sinus node ectopically express PITX2 at physiological dosages in a heterogeneous pattern. The prenatal delB sinus node forms discrete subdomains showing PITX2 dosage-dependent mild or severe loss of pacemaker cardiomyocyte identity. Respective subdomain sizes and severity of sinus node dysfunction and atrial arrhythmia susceptibility align with PITX2 dosage. Ectopic PITX2c expression in human induced pluripotent stem cell-derived pacemaker cardiomyocytes causes PITX2 dosage-dependent transcriptional and electrophysiological changes paralleling those in delB mice. Our findings provide a mechanistic link between genetic variation–driven ectopic PITX2 expression, sinus node dysfunction and atrial arrhythmogenesis, illustrating how spatiotemporally defined increases in transcription factor dosage can translate into developmental defects and disease predisposition.
1 October 2022 in The Natural Products Journal
Aim: Herein, we determined the anti-amoebic properties of propolis collected from different regions in Iran against Naegleria fowleri and Balamuthia mandrillaris. Background: Natural products remain a valuable source of compounds that are biologically active. Approximately one-third of well-known therapeutic drugs worldwide are derived from natural products. Objectives: Considering the use of propolis in folk medicine, here, for the first time, we evaluated anti-amoebic properties of propolis against free-living pathogenic amoebae, B. mandrillaris and N. fowleri. Methods: Propolis was collected from different regions of Iran and ethanolic extracts were prepared. Amoebicidal and cysticidal assays were accomplished to determine the effects of propolis against N. fowleri and B. mandrillaris. In vitro cytotoxicity assays were carried out to establish propolis effects on host cell damage. Finally, propolis metabolites were determined using spectrometric methods. Results: It was observed that propolis exhibited potent antiamoebic effects against trophozoites and cysts of both N. fowleri and B. mandrillaris at μg concentrations. When tested against cysts of both amoebae, only selected propolis exhibited cysticidal properties. The best activity was observed by propolis from the Kermanshah region, which depicted more than 95% amoebicidal activity and more than 60% cysticidal activity against both amoebae, respectively. Liquid chromatography- tandem mass spectrometry revealed that each extract is comprised of various components. Conclusion: For the first time, we showed that propolis has amoebicidal activity against both amoebae tested. Investigation into the individual activity of the components of propolis extracts and their mechanism of action against the aforementioned parasites might lead to the discovery of novel anti-amoebic compounds.